GLN-OLMESARTAN
GLENMARK PHARMACEUTICALS CANADA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of GLN-OLMESARTAN in Canada?
Yes. GLN-OLMESARTAN 40MG has an active shortage reported to Health Canada (last updated October 29, 2026).
Why is GLN-OLMESARTAN not available?
The reason the manufacturer reported: Demand increase for the drug.
When will GLN-OLMESARTAN be available again?
The manufacturer's estimated resolution date is November 27, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
JAMP OLMESARTAN
JAMP PHARMA CORPORATION
OLMESARTAN
PRO DOC LIMITEE
Other Products
GLN-OLMESARTAN
GLENMARK PHARMACEUTICALS CANADA INC.
SANDOZ OLMESARTAN
SANDOZ CANADA INCORPORATED
OLMETEC
ORGANON CANADA INC.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-11-27
~15 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02469820
Strength
40MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
OLMESARTAN MEDOXOMIL
Tier
Unrated
Last Updated
2026-10-29
Reason for Shortage
Demand increase for the drug.
Past Reports for This Drug
GLN-OLMESARTAN has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from GLENMARK PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02466783
DIN 02462060
DIN 02421437
DIN 02421445
30MG · DIN 02518910
750MG · DIN 02528495
20MG · DIN 02544369
5MG · DIN 02519852
10MG · DIN 02519860
600MG · DIN 02410990
800MG · DIN 02411008
20MG · DIN 02469812